Viewing Study NCT05980806

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:17 PM
Ignite Modification Date: 2026-01-13 @ 7:38 AM
Study NCT ID: NCT05980806
Status: RECRUITING
Last Update Posted: 2025-02-05
First Post: 2023-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Sponsor: Karyopharm Therapeutics Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis View
None Moderate Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelofibrosis View
None Selinexor View
None Total Symptom Score View
None Myelofibrosis Symptom Assessment Form View
None Spleen Volume Reduction View
None TSS50 View
None SVR35 View
None JAK2 View
None KPT-330 View
None Pacritinib View
None Ruxolitinib View
None Momelotinib View
None Thrombocytopenia View